Overview

Placebo-controlled Study Evaluating the Efficacy and Safety of Vardenafil in Subjects With Erectile Dysfunction

Status:
Completed
Trial end date:
2003-05-01
Target enrollment:
Participant gender:
Summary
This study tested the hypothesis that vardenafil was both clinically effective and well-tolerated compared to placebo in men diagnosed as being unresponsive to sildenafil.
Phase:
Phase 2/Phase 3
Details
Lead Sponsor:
Bayer
Collaborator:
GlaxoSmithKline
Treatments:
Vardenafil Dihydrochloride